Stock pledge default: Berry Genomics’ controlling shareholder will be forcibly converted into cash for approximately 3,535,200 shares by the court.

Beijing Business Daily News (Reporter Ding Ning) On the evening of April 1, BGI Genomics (000710) issued an announcement stating that, due to a default in the stock pledge repurchase business conducted by Gao Yang at Guosen Securities Co., Ltd., the Chengyu Financial Court ruled to forcibly liquidate the shares held by Gao Yang—3.5352 million shares of “BGI Genomics”—accounting for 0.999% of the company’s total share capital.

According to the announcement, Gao Yang holds 21.3831 million shares of BGI Genomics (representing 6.05% of the company’s total share capital), and is the company’s controlling shareholder.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin